Advanced Enzyme Technologies has announced a public buyback of its equity shares, valued at up to ₹200 crore. The buyback program is set to commence on August 14, 2026, and will conclude on November 20, 2026, or earlier if the maximum buyback size is deployed. This initiative aims to return capital to shareholders and potentially enhance earnings per share.
Advanced Enzyme Technologies Announces Share Buyback
Advanced Enzyme Technologies Limited has formally initiated a public announcement for the buyback of its equity shares. This decision follows the outcome of a Board Meeting held on August 08, 2026. The buyback is being conducted in accordance with the provisions of the Securities and Exchange Board of India (Buyback of Securities) Regulations, 2018.
Key Details of the Buyback
The maximum amount to be deployed for this buyback program is ₹200 crore. The buyback will officially open for tendering on August 14, 2026. The program is scheduled to close on November 20, 2026, which is sixty-six working days from the opening date. However, the buyback may also conclude earlier if the company deploys the full buyback amount or if the Board determines an earlier closure, provided the minimum buyback size has been deployed.
Public Announcement Details
The public announcement regarding the buyback has been made in the following newspapers:
- Financial Express (English National Daily) – All Editions
- Jansatta (Hindi National Daily) – All Editions
- Nav Shakti (Marathi i.e. Regional Language Daily) – Mumbai Edition
The company has highlighted that all payment obligations related to the buyback will be completed before the final closing date.
Source: BSE
